| IDORSIA AG SF-,05 |
| Schweiz |
| Gesundheit |
| CH0363463438 / A2DTEB |
| 19T (Frankfurt) |
| FRA:19T, ETR:19T, 19T:GR |
| - |
| https://www.idorsia.com/ |
|
Idorsia Ltd. is a Swiss-based biopharmaceutical co..
>Volltext.. |
| 918.34 Mio. EUR |
| 2223.08 Mio. EUR |
| 231.22 Mio. EUR |
| -166.26 Mio. EUR |
| -129.61 Mio. EUR |
| -0.68 EUR |
| 1409.95 Mio. EUR |
| 77.97 Mio. EUR |
| -280.74 Mio. EUR |
| 0.24 |
| 72.26% |
| -530.72% |
| - |
| - |
| - |
| - |
| IDORSIA |
| 30.10.25 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|